Skip to content
JP EN

HUMAN OS UPDATE

Understand and update the body over time.

ExoEarth is a life science company guided by HUMAN OS UPDATE, a concept for understanding changes in the body over time. With research and design, quality standards, operational protocols, data and intellectual property at our core, we collaborate with medical institutions, universities, research institutions and companies.

Measure. Understand. Plan. Act and intervene. Then measure again.

SCROLL

VISION

 Our Vision

HUMAN OS
UPDATE
Guiding Concept

HUMAN OS UPDATE is ExoEarth's overarching concept: continuously understanding changes in the body and reviewing actions in light of its condition at each point in time.

Business Foundation

A Platform-Based Business Model

To translate this concept into business, ExoEarth is building a platform centered on research and design, quality standards, operational protocols, data and intellectual property, working with partners responsible for manufacturing, medical care and measurement.

We are currently developing a business foundation that connects measurement, medical collaboration, food and data to put HUMAN OS UPDATE into practice.

Biological Design IP

EXOCURE Base-EV

EXOCURE Base-EV is ExoEarth's research and design foundation, integrating EV research, design, quality standards and operational protocols.

IP here refers to intellectual property relating to research and design; it does not refer exclusively to registered patents or rights already granted.

WHY NOW

 Why Start Now?

Your past personal data
cannot be created
retroactively.

Advances in AI and data use are making it increasingly possible to organize measurements and lifestyle information from different points in time and track changes over time.

However, the past personal data needed to understand changes in the body cannot be created retroactively.

Starting measurement and recordkeeping while healthy, and establishing a basis for ongoing observation, are important for understanding future health status and considering next steps.

ExoEarth is building a business foundation that connects measurement, recording, understanding, practice and remeasurement over time to track individual changes continuously.

COLLABORATION

 Our Partners and Activities

With Medical Institutions

We contribute to research, design, quality standards and operational protocols for EXOCURE-related programs operated under physicians' judgment. Medical institutions provide the medical care itself.

With Universities and Research Institutions

We pursue collaborative research and academic collaboration in EVs, glycans and biological analysis. Specific research topics are introduced according to each research plan and the information approved for public disclosure.

With Companies and Business Partners

We pursue business and research collaborations in measurement, food, data and international development.

For Participants

Through partner medical institutions and individual programs, we are progressively offering initiatives combining measurement, practice, ongoing observation and remeasurement.

LONGEVITY CYCLE

 Longevity Cycle

 Measure. Understand.
Plan the next steps.
Act and intervene.
Then measure again.

After ACTION, RE-MEASURE as needed and return to MEASURE. Remeasurement helps identify changes, informing further understanding and review of the next strategy.

  1. 01MEASURE

    Measure 

    We use information such as GlycanAge, CGM, blood tests, physical function and lifestyle information to understand the body's current condition.

  2. 02UNDERSTAND

    Understand 

    Physicians and specialists review measurements and their progression over time to assess conditions and changes.

  3. 03STRATEGY

    Plan 

    Medical decisions are distinguished from everyday lifestyle actions when considering next steps for each individual.

  4. 04ACTION

    Act / Intervene 

    Partner medical institutions perform medical procedures under physicians' judgment. In food and lifestyle fields, ExoEarth pursues research, development and phased provision.

RE-MEASURE | Measure again as needed and return to measurement

This basic cycle is being implemented in stages at partner medical institutions and through initiatives such as Champion Method.

EXOCURE AI is an ExoEarth research and development concept.
We are currently organizing available data and developing an analytics infrastructure.
It is not offered as a system for diagnosis or determining treatment plans.
Medical decisions are made by physicians at partner medical institutions.

CURRENT INITIATIVES

 Current Activities and Development Stages

01

EXOCURE 

Operating at Partner Medical Institutions

An EV-related program operated under physicians' judgment. ExoEarth contributes to research, design, quality standards and operational protocols.

02

GlycanAge 

Expanding Access in Japan / Collaborative Research Planning

We are working to expand access in Japan to GlycanAge testing, which analyzes IgG glycans, while planning collaborative research connecting EV research and glycan biomarkers.

03

Champion Method 

Pilot Operation

A program combining measurement, practice, ongoing observation and remeasurement.

04

EXOFOOD / EXOZEN 

R&D / Phased Provision

We pursue research, development and phased provision in food and everyday lifestyle fields.

05

RWD Analytics Infrastructure 

Infrastructure in Development

We are organizing available data from real-world operations and developing an analytics infrastructure for future scientific validation.

06

EXOCURE AI 

R&D Concept / Analytics Infrastructure in Development

An ExoEarth research and development concept. We are currently organizing available data and developing an analytics infrastructure. It is not offered as a system for diagnosis or determining treatment plans.

07

Education, Certification and Licensing

Foundation Building / Future Development

We are considering development based on quality standards, protocols and intellectual property.

EXPERIENCE & DATA

 Operational Experience and Data Infrastructure

Since 2019

Approximately5,000cumulative uses

EXOCURE-related programs
at partner medical institutions

Since 2019, EXOCURE-related programs at partner medical institutions have recorded approximately 5,000 cumulative uses in private, self-pay medical care.

This figure does not represent unique individuals or the number of people with complete longitudinal data for the same measures. It does not demonstrate any particular efficacy or safety. Medical records are managed by each medical institution.

ExoEarth is organizing data available through the necessary procedures and developing an analytics infrastructure for future scientific validation.

A laboratory image illustrating collaboration with universities and research institutions

ACADEMIC COLLABORATION

 University and Research Collaboration

ExoEarth is pursuing collaboration with universities and research institutions.

Tokyo Medical UniversityInstitute of Science Tokyo

Tokyo Medical University is proceeding with internal procedures toward establishing an endowed chair.
We are pursuing collaborative research and academic collaboration with Institute of Science Tokyo.

Activities with each university and research institution proceed according to its research plan and the information approved for public disclosure.

By connecting the expertise of medical institutions, universities, research institutions and companies, we aim to establish a research foundation in EVs, glycans, biological data, food and longevity.

  • EV
  • Glycans
  • Biological Data
  • Food
  • Longevity

STRATEGIC PARTNERSHIP

 Strategic Collaboration
with GlycanAge

ExoEarth has initiated a strategic collaboration with UK-based GlycanAge Ltd. under a Memorandum of Understanding (MOU).

ExoEarth is working to expand access to GlycanAge testing in Japan while planning collaborative research connecting EV research and glycan biomarkers.

Specific study designs will be determined following the necessary scientific, medical, ethical and regulatory review.

Logo of strategic collaboration partner GlycanAge

OUR STORY

 An Individual Example of Repeated Measurement

Award visual for Takashi Nishihira's GlycanAge Champion 2026 recognition

Takashi Nishihira, Representative Director, ExoEarth

 GlycanAge Champion 2026
Immune Health Champion

ExoEarth Representative Director Takashi Nishihira, aged 67 at the time of the award, has continued GlycanAge testing since his sixties and was selected as GlycanAge Champion 2026 – Immune Health Champion in 2026.
His chronological age at sample collection was 66, his GlycanAge measurement result was 20, his Age Gap was −46 years, and his Percentile Rank was Top 1%.

Note: This award and these measurements concern Takashi Nishihira's personal results and ongoing efforts. They do not demonstrate medical or rejuvenation effects of any particular product or service, or the outcomes of collaborative research.

Explore GlycanAge Champion

CONTACT

 Contact

ExoEarth Contact Form

Research and Business Inquiries

Collaborative research, academic collaboration, business partnerships, international business, GlycanAge, media and speaking engagements, investment and capital partnerships, and general inquiries

Contact ExoEarth

LATEST UPDATES

News

Update
Our redesigned official website is now available in Japanese and English.
Release
We published a press release on our strategic collaboration with UK-based GlycanAge.Press Release (PDF) ↗
Release
We published a press release on the Longevity 2.0 concept.Press Release (PDF) ↗
Concept
The ExoEarth Global 2026 Concept page is now available.
Science
We will progressively share information on Exosome Science, AI Analysis and Longevity.
Global
The ExoEarth Global 2026 English website is now available.
Update
The initial release of the redesigned ExoEarth Global 2026 website is now available.